DE69621786T2 - Aminotetralinderivat zur behandlung von herzkreislauferkrankung - Google Patents

Aminotetralinderivat zur behandlung von herzkreislauferkrankung

Info

Publication number
DE69621786T2
DE69621786T2 DE69621786T DE69621786T DE69621786T2 DE 69621786 T2 DE69621786 T2 DE 69621786T2 DE 69621786 T DE69621786 T DE 69621786T DE 69621786 T DE69621786 T DE 69621786T DE 69621786 T2 DE69621786 T2 DE 69621786T2
Authority
DE
Germany
Prior art keywords
aminotetral
derivative
treatment
heart circular
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69621786T
Other languages
English (en)
Other versions
DE69621786D1 (de
Inventor
Paolo Chiesi
Stefano Bongrani
Roberta Razetti
Maurizio Civelli
Alberto Umile
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chiesi Farmaceutici SpA
Original Assignee
Chiesi Farmaceutici SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farmaceutici SpA filed Critical Chiesi Farmaceutici SpA
Publication of DE69621786D1 publication Critical patent/DE69621786D1/de
Application granted granted Critical
Publication of DE69621786T2 publication Critical patent/DE69621786T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
DE69621786T 1995-03-17 1996-03-13 Aminotetralinderivat zur behandlung von herzkreislauferkrankung Expired - Fee Related DE69621786T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT95MI000532A IT1275935B1 (it) 1995-03-17 1995-03-17 Derivato di aminotetralina per la terapia di malattie cardiovascolari
PCT/EP1996/001060 WO1996029065A2 (en) 1995-03-17 1996-03-13 Aminotetralin derivative for the therapy of cardiovascular diseases

Publications (2)

Publication Number Publication Date
DE69621786D1 DE69621786D1 (de) 2002-07-18
DE69621786T2 true DE69621786T2 (de) 2003-01-02

Family

ID=11370947

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69621786T Expired - Fee Related DE69621786T2 (de) 1995-03-17 1996-03-13 Aminotetralinderivat zur behandlung von herzkreislauferkrankung

Country Status (31)

Country Link
US (2) US6013678A (de)
EP (2) EP0814791B1 (de)
JP (1) JPH11502211A (de)
KR (1) KR100391143B1 (de)
CN (1) CN1112920C (de)
AT (1) ATE218856T1 (de)
AU (1) AU702656B2 (de)
BR (1) BR9607996A (de)
CA (1) CA2215671A1 (de)
CZ (1) CZ288488B6 (de)
DE (1) DE69621786T2 (de)
DK (1) DK0814791T3 (de)
EA (1) EA000937B1 (de)
EE (1) EE04040B1 (de)
ES (1) ES2177769T3 (de)
HK (2) HK1004802A1 (de)
HU (1) HUP9801686A3 (de)
IL (1) IL117518A (de)
IT (1) IT1275935B1 (de)
LT (1) LT4355B (de)
LV (1) LV11882B (de)
MX (1) MX9706971A (de)
NO (1) NO317402B1 (de)
NZ (1) NZ303993A (de)
PL (1) PL183347B1 (de)
PT (1) PT814791E (de)
SI (1) SI9620036B (de)
SK (1) SK282952B6 (de)
TR (1) TR199700963T1 (de)
WO (1) WO1996029065A2 (de)
ZA (1) ZA962073B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2695157B2 (ja) * 1986-12-29 1997-12-24 松下電器産業株式会社 可変パイプラインプロセッサ
WO2000076544A1 (en) * 1996-03-13 2000-12-21 Chiesi Farmaceutici S.P.A. Aminotetralin derivative for the therapy of cardiovascular diseases
SI1183046T1 (en) * 1999-06-09 2004-02-29 Chiesi Farmaceutici S.P.A. Aminotetralin derivative for the therapy of cardiovascular diseases
ES2206240T3 (es) 1999-06-09 2004-05-16 Chiesi Farmaceutici S.P.A. Derivados de aminotetralina para el tratamiento de trastornnos cardiovasculares.
IT1313583B1 (it) * 1999-07-30 2002-09-09 Chiesi Farma Spa Derivati 2-amminotetralinici per la terapia del glaucoma.
IL152751A0 (en) * 2000-05-12 2003-06-24 Chiesi Farma Spa Optically active 2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them
SE0101854L (sv) * 2001-05-28 2002-11-29 Bioneris Ab Användning av en förening med en negativt laddad region av grupper för behandling av restenos.
EP1384708A1 (de) * 2002-07-26 2004-01-28 CHIESI FARMACEUTICI S.p.A. Verfahren zur Herstellung der Form I von Nolomirol Hydrochlorid
US20050101668A1 (en) * 2003-07-24 2005-05-12 Chiesi Farmaceutici S.P.A. Aminotetralin derivatives as a medicament for the treatment and prevention of myocardial ischemic conditions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4134997A (en) * 1977-03-01 1979-01-16 University Of Iowa Research Foundation Effect of an aminotetralin derivative on coronary blood flow in infarcted hearts
SU998342A1 (ru) 1981-12-11 1983-02-23 Предприятие П/Я А-3732 Способ получени синтетического цеолита типа @
IT1218322B (it) * 1982-06-10 1990-04-12 Chiesi Farma Spa Derivati di 1,2,3,4-tetraidronaftalene,procedimento di preparazione e relative composizioni farmaceutiche

Also Published As

Publication number Publication date
CN1181699A (zh) 1998-05-13
EE04040B1 (et) 2003-06-16
EP1216702A2 (de) 2002-06-26
BR9607996A (pt) 1998-06-23
TR199700963T1 (xx) 1998-02-21
CN1112920C (zh) 2003-07-02
NZ303993A (en) 2000-12-22
IL117518A0 (en) 1996-07-23
ES2177769T3 (es) 2002-12-16
PT814791E (pt) 2002-10-31
SI9620036B (sl) 2002-10-31
AU702656B2 (en) 1999-02-25
HUP9801686A3 (en) 1999-10-28
IT1275935B1 (it) 1997-10-24
IL117518A (en) 2001-05-20
DE69621786D1 (de) 2002-07-18
CZ286697A3 (cs) 1998-03-18
EA000937B1 (ru) 2000-06-26
SI9620036A (sl) 1998-02-28
PL183347B1 (pl) 2002-06-28
US6013678A (en) 2000-01-11
SK282952B6 (sk) 2003-01-09
KR100391143B1 (ko) 2003-11-28
NO974267D0 (no) 1997-09-16
LV11882B (en) 1998-03-20
HK1004802A1 (en) 1998-12-11
MX9706971A (es) 1997-11-29
ITMI950532A0 (it) 1995-03-17
DK0814791T3 (da) 2002-10-07
LT97147A (en) 1998-02-25
ZA962073B (en) 1996-11-27
CA2215671A1 (en) 1996-09-26
ITMI950532A1 (it) 1996-09-17
WO1996029065A2 (en) 1996-09-26
EA199700243A1 (ru) 1998-02-26
EE9700231A (et) 1998-04-15
JPH11502211A (ja) 1999-02-23
CZ288488B6 (en) 2001-06-13
EP1216702A3 (de) 2002-09-04
ATE218856T1 (de) 2002-06-15
WO1996029065A3 (en) 1996-11-28
PL322284A1 (en) 1998-01-19
HUP9801686A2 (hu) 1999-06-28
HK1048060A1 (zh) 2003-03-21
US6103760A (en) 2000-08-15
AU5107296A (en) 1996-10-08
SK125497A3 (en) 1998-02-04
LT4355B (lt) 1998-06-25
LV11882A (lv) 1997-12-20
NO974267L (no) 1997-11-07
EP0814791B1 (de) 2002-06-12
KR19980703030A (ko) 1998-09-05
NO317402B1 (no) 2004-10-25
EP0814791A1 (de) 1998-01-07

Similar Documents

Publication Publication Date Title
BR9714363A (pt) Derivados de pirazol substituìdos para o tratamento de doenças circulatórias cardìacas
DE69200675D1 (de) Verwendung von Droloxifen bei der Behandlung von Knochenerkrankungen.
DE69434431D1 (de) Methoden zur behandlung von muskelerkrankungen und muskelstörungen
NO20075065L (no) Anvendelse av isoflavonforbindelser til a behandle hjertesykdom
DE69814394D1 (de) Verwendung von levobupivacain
DE69621786D1 (de) Aminotetralinderivat zur behandlung von herzkreislauferkrankung
ATE157871T1 (de) Arzneimittel zur therapeutischen und prophylaktischen behandlung von krankheiten, die durch hyperplasie der glatten muskelzellen bedingt sind
ATE192923T1 (de) Verwendung von boswelliasäure zur behandlung von hirntumoren
ATE151774T1 (de) Cyclopentanperhydrophenanthren-17-beta-(3-furyl - 3-derivate und pharmazeutische präparate davon, zur behandlung von kardiovaskulär-erkrankungen
DE69007065D1 (de) Verwendung von Diadenosin-5',5'''-p1,p4-tetraphosphat zur Herstellung eines Arzneimittels zur Behandlung von Herzkrankheiten.
TR199901385T2 (xx) Piperidin t�revleri.
ATE236159T1 (de) Neuartige bispidin-derivate, die sich zur behandlung von herzrhythmusstörungen eignen
ATE157670T1 (de) Digitoxigenin und dihydrodigitoxigenin 3-beta- derivate und pharmazeutische präparate davon, zur behandlung von hypertonie
DE68906028T2 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.
ATE91886T1 (de) Praeparat zur behandlung von erektionsstoerungen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee